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A B S T R A C T
Depression is a multidimensional condition encompassing affective, physiological, and cognitive
symptoms. Although depression’s high comorbidity with both epileptic and psychogenic nonepileptic
seizures (ES and PNES) has been established, few studies have addressedwhether the types of depressive
symptoms experienced differ by seizure type (ES and PNES). This study compared the self-reported
depressive symptomatology of patients (n = 60 ES and 59 PNES) who underwent video-EEG monitoring
and completed self-reported objective measures of psychopathology (PAI and BDI-II). Differences in
depressive symptoms were also compared by gender and among several subgroups with ES. Results
revealed the PNES group, particularly PNES females, endorsed a signiﬁcantly higher level of physiological
symptoms of depression as measured by the PAI DEP-P subscale than the ES group; the BDI-II did not
differ between groups. These ﬁndings have potential clinical implications for the identiﬁcation and
management of depressive symptoms among these patient groups.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Depression is themost frequent psychiatric disorder in patients
with epileptic seizures (ES) and has been increasingly recognized
as a signiﬁcant factor in the quality of life, morbidity, andmortality
of epilepsy patients.1,2 The prevalence of depression in patients
with ES has been estimated to be 3–9% among those with well-
controlled seizures1 and 20–55% in individuals with refractory
epilepsy.3 Additionally, some studies suggest the prevalence of
depression varies by seizure type with complex partial seizures,
particularly with left temporal lobe onset, having higher rates.4,5
The relationship between depression and epilepsy appears to be
complex and bidirectional, with potential commonalities in
treatments, neurotransmitter abnormalities, and neuropathologi-
cal processes.6
Depression is also common among patients with psychogenic
nonepileptic seizures (PNES), typically at a higher rate than in
patients with epileptic seizures.7 The estimated prevalence in
PNES is 20–40% in thosewho are referred to epilepsy centers8,9 and
as high as 85% in some samples.10* Corresponding author at: Department of Clinical Neuropsychology, Barrow
Neurological Institute, 222 West Thomas Road, Suite 315, Phoenix, AZ 85013,
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doi:10.1016/j.seizure.2009.05.006With regards to gender differences in these populations,
Holmes et al.11 demonstrated that relative to male PNES patients,
men with ES and women with either ES or PNES exhibited
signiﬁcantly higher elevations on multiple scales of a psycho-
pathology measure (MMPI), including depression. Interestingly,
both left and right seizure onset groups have produced signiﬁ-
cantly elevated depression scores on the same measure.12
Depression is a multidimensional condition encompassing
affective, physiological, and cognitive symptoms. Although
depression’s high comorbidity with both ES and PNES has been
established, few studies have addressed whether the types of
depressive symptoms experienced by these groups differ. Some
preliminary studies have suggested that PNES patients are more
likely to endorse the physiological symptoms of depression.13–15
The present study addressed this issue by comparing the self-
reported depressive symptoms of patients with ES and PNES on an
inpatient epilepsy monitoring unit. In addition, gender differences
within and between groups were examined. Finally, differences in
self-reported depressive symptoms were also compared between
several subgroups with ES.
2. Methods
2.1. Participants
The present research retrospectively examined the self-
reported depressive symptomatology of patients (n = 60 ES andvier Ltd. All rights reserved.
Table 2
Mean scores on measures of self-reported depressive symptoms for ES and PNES
patients broken down by gender.
Measure ES females ES males PNES females PNES males
Mean (SD) Mean (SD)
BDI-II (raw score) 12.4 (9.2) 10.3 (9.4) 13.8 (9.3) 12.2 (10.3)
PAI (T-score)
DEP 56.7 (12.2) 52.5 (11.5) 58.1 (11.6) 54 (9.6)
DEP-C 54.6 (11.7) 52.8 (11.6) 53 (11.1) 51 (10)
DEP-A 52.4 (10.2) 51.3 (11.9) 52.3 (11.4) 52.5 (11.6)
DEP-P 59.4 (13.8)* 52.2 (11.5)* 64.9 (11.5)** 55.9 (8.5)**
* Scores differ at p = 0.05.
** Scores differ at p < 0.01.
Table 3
Mean scores (SD) on measures of self-reported depressive symptoms for ES
subgroups.
PAI
BDI-II DEP DEP-C DEP-A DEP-P
Temporal lobe
(n = 23)
9.6 (7.4) 54.0 (9.9) 53.1 (9.6) 50.3 (8.2) 56.4 (12)
Extra-temporal
(n = 6)
12.2 (8.7) 48.0 (8.3) 50.0 (8.8) 45.3 (4.8) 50.0 (11.9)
R onset (n = 16) 9.1 (7.2) 54.5 (11.1) 51.8 (9.8) 51.3 (8.9) 57.7 (12.7)
L onset (n = 8) 12.4 (8.7) 57.0 (8.5) 58.6 (8.6) 51.3 (7.4) 58.0 (12.2)
Partial onset
(n = 29)
13.0 (9.1) 55.2 (12.5) 54.5 (12.5) 51.3 (11.4) 56.8 (13.7)
Generalized onset
(n = 8)
15.4 (9.4) 60.6 (12) 60.8 (11.9) 56.3 (14.3) 60.0 (11.4)
No signiﬁcant differences were observed.
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neuropsychological testing including self-reported objective mea-
sures of psychopathology. The ES group was comprised of 29 men
and 31womenwith amean age of 36.7 (SD = 12.2), mean education
level of12.86 (SD = 2.2), andmeanWASIFSIQof93.5 (SD = 14.8). The
PNES group included 27 men, 32 women with a mean age of 40.9
(SD = 13.6),mean education level of 13.09 (SD = 2.1), andmean IQ of
99.2 (SD = 13.7). The ES subgroups examined included temporal
(n = 23) vs. extra-temporal (n = 6), right onset (n = 16) vs. left onset
(n = 8), and partial (n = 29) vs. generalized onset (n = 8). St. Joseph’s
Hospital’s Institutional Review Board approved the inclusion of all
patients’ data in the study.
2.2. Measures
The Beck Depression Inventory-Second Edition (BDI-II), a
reliable and valid self-report measure consisting of 21 items,
has been commonly used to assess depressive symptoms in both
research and clinical settings. It assesses the severity of recent
depressive symptoms by evaluating DSM-IV criteria for depressive
disorders.16
The Personality Assessment Inventory (PAI)17 is a 344 item self-
report measure of psychiatric symptomatology. The PAI yields a
DEP clinical scale which measures features common to the
syndrome of depression and three subscales reﬂecting the major
constellations of depressive symptomatology: cognitive symp-
toms such as feelings of worthlessness and concentration
difﬁculties (DEP-C); affective symptoms such as sadness or
anhedonia (DEP-A); and physiological symptoms such as fatigue
and disturbances in sleep, appetite, and libido (DEP-P).
3. Results
3.1. Comparisons between ES and PNES groups
The ES and PNES groups did not differ signiﬁcantly on any of the
demographic variables. Omnibus multiple analysis of variance
(MANOVA) yielded statistically signiﬁcant [F(13,105) = 3.57,
p < 0.01] differences between the self-reported depressive symp-
toms of the PNES and ES groups. Although their overall levels of
depressive symptomatology did not differ, the PNES group
endorsed a signiﬁcantly higher level of physiological symptoms
of depression as measured by the PAI DEP-P subscale than the ES
group (see Table 1; [F(1,117) = 5.76, p < 0.05]). The PNES group’s
DEP-P mean score was above average relative to the normative
sample; a T-score of 61 is at the 86th percentile.
Gender differences were also examined. Comparison of the self-
reported depressive symptoms between PNES females and males
yielded a statistically signiﬁcant difference (omnibus MANOVA
[F(5,53) = 2.77, p < 0.01]). Relative to males with PNES, females
with PNES reported a signiﬁcantly higher level of physiological
symptoms of depression as measured by the PAI DEP-P subscale
[F(1,57) = 11.35, p < 0.01]). Gender comparisons among the ESTable 1
Mean scores on measures of self-reported depressive symptoms for ES and PNES
patients.
Measure ES mean (SD) PNES mean (SD)
BDI-II (raw score) 11.0 (9.0) 13.3 (9.6)
PAI (T-score)
DEP 54.3 (11.2) 56.46 (11.0)
DEP-C 53.5 (11.5) 51.7 (10.3)
DEP-A 51.5 (10.4) 52.8 (11.4)
DEP-P 55.7 (12.6)* 61.3 (11.6)*
* Scores differ at p < 0.01. A T-score of 61 is at the 86th percentile in the
normative sample.group yielded a trend for females to endorse higher levels of
physiological depression than males [F(1,58) = 3.80, p = 0.05].
Comparison of the female patients with ES vs. PNES yielded a
trend for the PNES females to endorse higher levels of physiological
depression (DEP-P) (Table 2). Among the men in the study, there
were no signiﬁcant differences in self-reported depressive
symptoms between those with ES vs. PNES.
3.2. Comparisons between ES subgroups
Analyses yielded no signiﬁcant differences between the ES
subgroups (i.e., temporal vs. extra-temporal, right onset verse left
onset, or partial onset vs. generalized onset) (Table 3). The
aforementioned results should be taken in the context of
disproportionate numbers in each group, with some groups having
limited sample size.
4. Discussion
Although the overall levels of self-reported depressive symp-
toms did not differ between the ES and PNES groups, there were
signiﬁcant differences in the types of depressive symptoms
endorsed by the two groups. Gender comparisons suggested this
ﬁnding was largely attributable to the signiﬁcantly higher rate of
physiological symptoms of depression among the female patients
with PNES. Relative to normative data, the self-reported level of
overall depressive symptomswas at the upper end of normal limits
for both patient groups; and when the different dimensions of
depressive symptomswere considered, the PNES group endorsed a
mildly elevated rate of physiological symptoms. Female partici-
pants with PNES had an average level of depression symptom
endorsement that approached clinical levels. Furthermore, treat-
ing the scores as categorical (elevated or not; T  65) rather than
continuous did not yield signiﬁcantly different ﬁndings between
groups except in the case of PNES females; 50% of PNES females
had elevations on the physiological symptoms of depression
S.B. Asmussen et al. / Seizure 18 (2009) 564–566566subscale compared to only 18% of PNES males. Elevations on these
self-report measures are not equivalent to a diagnosis of major
depression, but are useful in identifying patients in need of further
psychiatric evaluation.18
What types of depressive symptoms patients are experiencing
can inﬂuence treatment selection and has clinical implications
for the identiﬁcation of depression among patients in an EMU or
epilepsy clinic setting. Our results suggest patients with PNES
may be at increased risk of being under diagnosed with
depression. Given their propensity to express their emotional
distress as somatic symptoms, they may not recognize their
physiological symptoms as related to depression and might be
more likely to present for medical than psychiatric care.
Furthermore, some of the brief screening measures designed
to screen for depression among epilepsy patients (e.g., Neuro-
logical Disorders Depression Inventory for Epilepsy; NDDI-E19;
do not include more physiological symptoms in efforts to
minimize the potential impact of AED side effects. Our ﬁndings
highlight the importance of multidimensional assessment of
depressive symptoms and inquiring about vegetative as well as
affective aspects of the condition in settings where PNES as well
as ES patients are present. Untreated depression presents an
economic burden (increased disability and utilization of medical
services), negatively impacts patients’ quality of life, and may
trigger expression of conversion disorder among those patients
prone to PNES.20,21
No signiﬁcant differences in depressive symptoms were
observed when comparing the different epilepsy subgroups. The
present study’s ability to explore the differences in depressive
symptoms among the ES subgroups was limited by the small
sample sizes in some groups and these ﬁndings should be explored
with a larger sample size.
Given this was archival data the actual rate of diagnosed
depression and identiﬁcation of persons in treatment for depres-
sion was not available and should be heavily considered in future
research.
The present study was also limited to examination of only
depressive symptoms; we plan to examine differences in other
forms of psychopathology (e.g., anxiety, PTSD, somatization)
among EMU patients in future research.References
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